Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tessera Therapeutics
Research
ASGCT 2023: New preclinical updates from Tessera, Tune and more
Epigenetic editing in primates. Cytokine-expressing AAVs for glioma. Here are some of the biotech highlights from ASGCT's annual meeting.
Helen Floersh
May 23, 2023 10:00am
Biotech's top money raisers: 2022
Apr 11, 2023 9:19am
Tessera makes the case for gene writing tech at JPM
Jan 17, 2023 12:56pm
Execs contemplate gene editing's next 10 years
Oct 3, 2022 3:00am
Former Takeda exec takes reins at Tessa—Chutes & Ladders
Aug 26, 2022 9:30am
Tessera snags bluebird's chief regulatory officer
Aug 24, 2022 11:07am
